AOD-9604 comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2026-08-01. Numbers and descriptions here follow the published literature rather than marketing material.
AOD-9604 is a synthetic peptide whose sequence matches the C-terminal fragment of human growth hormone, specifically residues 176 through 191. This region differs from the full hormone in its receptor interactions. The peptide is not a growth hormone secretagogue and does not bind the growth hormone receptor in the same manner. Researchers have examined it for effects on lipid metabolism, but its exact pharmacological profile remains an active area of study.
Development of AOD-9604 began in the 1990s as scientists sought to isolate metabolic effects of growth hormone without its growth-promoting actions. Early laboratory work focused on fat cells and animal models. Several human trials followed, examining changes in body composition and fat mass. Results have been mixed, and the peptide has not progressed to widespread clinical approval. Interest continues in research settings, particularly regarding its mechanism and potential metabolic targets.
AOD-9604 is a synthetic peptide that corresponds to a short section of human growth hormone. It is commonly identified as hGH fragment 176-191 because its sequence matches residues at the C-terminal end of the hormone. The molecule contains sixteen amino acids and is made by solid-phase peptide synthesis. Researchers study it for metabolic effects rather than for the growth-promoting actions associated with full human growth hormone. Its small size distinguishes it from the complete 191-amino-acid hormone.
Several names appear in scientific and commercial settings. AOD9604 and AOD-9604 are development codes used interchangeably, while hGH fragment 176-191 describes the same region. The peptide includes a disulfide bond between two cysteine residues, which helps shape its three-dimensional structure. Different suppliers may provide acetate or other salt forms, and purity can vary. These differences matter because analytical tests and biological assays can respond to the specific form being studied.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Peptide fragment | Corresponds to hGH residues 176-191 |
| Common synonyms | AOD9604, hGH 176-191 | Also written as AOD-9604 |
| Typical form | Lyophilized powder | Often supplied in sealed vials |
| Solubility | Water-soluble | Dissolves in aqueous buffers |
| Regulatory status | Not approved as drug | Banned in sport; varies by country |
The compound has been studied as a potential treatment for obesity and related metabolic conditions. Published trials have examined changes in body weight, fat mass, and safety markers over limited durations. Results have been mixed or modest, and no large-scale outcome trials are established. Regulatory agencies in several countries have not approved it as a therapeutic drug. Some commercial products have been marketed outside regulated pharmaceutical channels, which raises questions about quality and claims.
In the scientific literature, AOD-9604 appears in reviews of growth hormone fragments and in discussions of peptide-based metabolic research. Some sources distinguish it from growth hormone itself, while others group it with compounds marketed for weight management. The evidence base is small compared with approved obesity medications. Questions about long-term efficacy and clinical relevance remain open, and independent replication of key findings is limited. Most published reports are early-stage and exploratory.
In laboratory settings, AOD-9604 is commonly supplied as a lyophilized powder and stored cold to limit degradation. Reconstituted solutions are typically kept refrigerated or frozen, depending on the buffer and concentration, and protected from repeated freeze-thaw cycles. Stability can be influenced by pH, temperature, and the presence of proteases. Purity is usually assessed by high-performance liquid chromatography and mass spectrometry. These practices support reproducibility, but they do not imply safety or efficacy for any human use.
Regulatory status: AOD-9604 is not approved as a therapeutic drug in the United States, European Union, or other major markets. It is listed by the World Anti-Doping Agency as a prohibited substance in sport, specifically under growth hormone fragments. Many jurisdictions restrict its sale for human consumption. Products marketed online may not meet pharmaceutical quality standards. The legal status varies by country and often depends on whether the material is presented as a research chemical, supplement, or drug.
Detection and characterization of AOD-9604 in research and anti-doping settings typically rely on mass spectrometry coupled with liquid chromatography. These methods can identify the peptide by its mass and fragmentation pattern. Immunoassays may also be used in some screening contexts, but they can cross-react with related peptides. Because the molecule is small and may be present at low concentrations, sample preparation and method validation are important. Confirmatory analysis usually requires comparison with a certified reference standard.
Thebaine (paramorphine), also known as codeine methyl enol ether, is an opiate alkaloid, its name coming from the Greek Θῆβαι, Thēbai (Thebes), an ancient city in Upper Egypt. A minor constituent of opium, thebaine is chemically similar to both morphine and codeine, but has stimulatory rather than depressant effects. At high doses, it causes convulsions similar to strychnine poisoning. The synthetic enantiomer (+)-thebaine does show analgesic effects apparently mediated through opioid receptors, unlike the inactive natural enantiomer (−)-thebaine. While thebaine is not used therapeutically, it is the main alkaloid extracted from Papaver bracteatum (Iranian opium / Persian poppy) and can be converted industrially into a variety of compounds that do have medicinal value.
Located close to the city centre, the university campus stretches along the River Corrib. The oldest part of the university, the Quadrangle with its Aula Maxima, was designed by John Benjamin Keane in a Tudor Gothic architectural style and was constructed from local limestone; it is a replica of Christ Church, one of the colleges at the University of Oxford. The Queen's University was dissolved on 3 February 1882 under the University Education (Ireland) Act 1879, and was replaced by the Royal University of Ireland (RUI), which had been established on 27 April 1880. Under the Irish Universities Act 1908, the RUI was dissolved and was replaced by the National University of Ireland (NUI) and Queen's University of Belfast (QUB). The name of Queen's College, Galway, was changed to University College, Galway (UCG), and it became a constituent college of the new National University of Ireland, together with University College Dublin (UCD), and University College Cork (UCC). Queen's College, Belfast, became an independent university, called the Queen's University of Belfast. University College, Galway (UCG), was given special statutory responsibility under the University College Galway Act 1929 with respect of the use of the Irish language as a working language of the university. Members of the Franciscan Order from St. Anthony's College would have studied for degrees in UCG, similarly members of the Society of African Missions at their House of Philosophy, at Cloughballymore, Kilcolgan, Co Galway, studied for degrees in UCG. St. Anthony's is now used by the J.E.
==== Liquid samples ==== Liquid samples can be sandwiched between two plates of a salt—commonly sodium chloride, but a number of other salts such as potassium bromide or calcium fluoride are sometimes. The plates themselves are transparent in the infrared band, allowing the IR effects of the sample itself to be seen through them without substantial interference. If the IR spectrum of the plates themselves is known, this "background spectrum" can be subtracted from the experimental spectrum of the sample to remove artifacts and allow the spectrum of the substance of interest to be seen more clearly. Solutions can also be measured and then the spectrum of the solvent, which would otherwise overwhelm the experimental spectrum, to be removed.
Sources: en.wikipedia.org
During 1977, Czernilofsky published research that used affinity labeling to identify tRNA-binding sites on rat liver ribosomes. Several proteins, including L32/33, L36, L21, L23, L28/29 and L13 were implicated as being at or near the peptidyl transferase center.
In the early 17th century, the majority of the labour in Barbados was provided by European indentured servants, mainly English, Irish and Scottish, with African and native American slaves providing little of the workforce. The introduction of sugar cane in 1640 completely transformed society and the economy. Barbados eventually had one of the world's largest sugar industries. The workable sugar plantation required a large investment and a great deal of heavy labour. At first, Dutch traders supplied the equipment, financing, and African slaves, in addition to transporting most of the sugar to Europe. In 1644, the population of Barbados was estimated at 30,000, of which about 800 were of African descent, with the remainder mainly of English descent. By 1700, there were 15,000 free whites and 50,000 enslaved Africans. In Jamaica, although the African slave population in the 1670s and 1680s never exceeded 10,000, by 1800 it had increased to over 300,000. The increased implementation of slave codes or black codes, which created differential treatment between Africans and the white workers and ruling planter class. In response to these codes, several slave rebellions were attempted or planned during this time, but none succeeded.
Knights of Saint John, Supreme Ladies Auxiliary - Female auxiliary of above; open to "practical Catholic ladies" ages 16–55. Social membership available was also available, even to those over 55. Those under 8-16 can join the junior auxiliary. In April 1978 there were 14,251 members. The highest authority is the "Supreme Convention" which meets biennially. State structures are "Grand Auxiliaries", which meet annually, and locals "Subordinate Auxiliaries". There were 161 of these in the US in 1978, as well as 28 in foreign countries. Headquarters were in Rochester, New York. The group has a secret ritual, a uniformed drill team, and death benefits. Supports mission work, Red Cross, American Cancer Society, American Heart Association, Muscular Dystrophy Association, National Foundation for Infantile Paralysis. Loyal Christian Benefit Association - Founded on April 6, 1890, as Ladies' Catholic Benevolent Association, originally for Catholic women. In 1927 any offspring from birth to 16 were eligible for fraternal insurance. In 1960 admitted Catholic husbands, brothers, and nephews. By 1979 open to Christians of good moral character and in good health. In 1967, it had 85,000 members and 51,369 in December 1978, 46,000 members in 1994. Headquarters in Titusville, Pennsylvania. Locals are Branches, national structure is called the "National Council".
== Prevention == Cara Myer, the author of "The Tea and Toast Syndrome: Psychosocial Aspects of Congregate Dining" suggests that congregate dining for older adults may be an excellent strategy to prevent tea and toast syndrome. Myer mentions that social service interventions for malnutrition, including congregate dining, are often under-utilized and could provide a stimulating environment that may improve the quality of life of many older adults. Further, general preventative measures focus on evaluating the nutrition of older adults, including keeping a record of weight patterns, helping with meal plans focusing on nutrient-rich foods, and using local services such as a meal delivery program. Additional strategies include:
Sources: en.wikipedia.org
AOD-9604 is a synthetic peptide fragment of human growth hormone, corresponding to amino acids 176-191. It is studied for potential effects on fat metabolism, but it is not approved as a drug in most countries. Its exact mechanism remains under investigation.
No, it is a small fragment of the full growth hormone protein. It does not appear to stimulate growth or increase growth hormone levels in the same way. Its actions are thought to be more limited to metabolic pathways.
Regulatory status varies. It is not approved for medical use in the United States or many other countries. It is banned in sport by WADA, and its sale as a supplement or research chemical may be subject to legal restrictions.
AOD-9604 is a synthetic peptide fragment of human growth hormone. It corresponds to the C-terminal region known as hGH 176-191 and is studied for metabolic effects. It is not an approved therapeutic drug.